Riskpilot← Back to searchSign inGet full accessHemigon Dermatologdoktorn AB
ABActiveOrg 5569808032Fjärde Långgatan 18 AMedical specialists activities · NACE 8622Est. 20141 employees
Revenue 2025
SEK 579K
-57% vs 2024
EBITDA margin
53.2%
-6% vs 2024
Equity ratio
58.6%
Financial strength
Net profit 2025
SEK 208K
-7% vs 2024
| Revenue | SEK 579K | -57% |
| EBITDA | SEK 308K | -6% |
| Net profit | SEK 208K | -7% |
| Total assets | SEK 1,9M | +16% |
| Equity | SEK 1,1M | +23% |
| Employees | 1 | — |
Legal name
Hemigon Dermatologdoktorn AB
Org number
5569808032
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
27 augusti 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Erbjuda hudläkarvård samt föreläsningar.
Address
Fjärde Långgatan 18 A
Email
dermatologdoktorn@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 364 | 2 203 | 1 700 | 1 344 | 579 |
| Staff expenses | — | — | — | −556 | −27 |
| EBITDA | 148 | 995 | 400 | 326 | 308 |
| Depreciation & amort. | −6 | −3 | −1 | — | — |
| EBIT | 142 | 992 | 399 | 326 | 308 |
| Net financials | −2 | — | 1 | 48 | 42 |
| Profit before tax | 139 | 892 | 401 | 281 | 263 |
| Tax | −29 | −184 | −84 | −57 | −54 |
| Net profit | 110 | 708 | 317 | 224 | 208 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 964 | 1 720 | 1 767 | 1 631 | 1 890 |
| Equity | 300 | 909 | 925 | 899 | 1 108 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 663 | 712 | 741 | 539 | 503 |
| Total debt | 663 | 712 | 741 | 539 | 503 |
EBITDA margin
53.2%
This company
15.8%
Market median
+237% vs market
20212025
Equity ratio
58.6%
This company
38.2%
Market median
+53% vs market
20212025
Return on equity
18.8%
This company
18.4%
Market median
+2% vs market
20212025
Net profit margin
36.0%
This company
8.1%
Market median
+344% vs market
20212025
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20212025
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HS Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hemigon Dermatologdoktorn AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helena Sook-Hee Gustavsson Gonzalez | Chief Executive Officer | 0 companies |
| Arne Roland Gustavsson | Board of Directors | 0 companies |
| Philip Arash Zanganeh | Deputy Board Member | 0 companies |